Ribavirin Pre-treatment Followed by Combined Standard Therapy in Hepatitis C Virus (HCV) Recipients

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2009
The results of antiviral therapy in patients with recurrent hepatitis C after liver transplantation are lower than standard. Ribavirin has immune-modulating effects and seems to be crucial to optimize viral treatment. The aim of this multicenter controlled study is to examine the effect of Ribavirin pre-treatment preceding the combination therapy with peginterferon plus ribavirin on the sustained virological response.
Epistemonikos ID: a8f8576fc799b67b10c6b69060ade33f8a527c80
First added on: Mar 23, 2020